← Alle mensen

AI

Arpad Illes

3 publicaties

PubMed → Google Scholar →

Publicaties op Oncologisch.com

Epcoritamab, lenalidomide, and rituximab versus lenalidomide and rituximab for relapsed or refractory follicular lymp...
Lancet (London, England) · 10 januari 2026
Fixed-Duration Acalabrutinib Combinations in Untreated Chronic Lymphocytic Leukemia.
The New England journal of medicine · 20 februari 2025
Acalabrutinib versus idelalisib-R of BR bij recidief CLL: ASCEND fase III
Journal of clinical oncology : official journal of the American Society of Clinical Oncology · 1 september 2020